Delayed pleural effusion after anterior thoracic spinal fusion using bone morphogenetic protein-2

Spine

Volumn 36, Issue 5, 2011, Pages

  Kepler, Christopher K ^a   Huang, Russel C ^a   Meredith, Dennis ^a   Cunningham, Matthew ^a   Boachie Adjei, Oheneba ^a  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

BMP 2; complication; pleural effusion; thoracic spinal fusion; thoracotomy

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; COLLAGEN SPONGE; FUROSEMIDE;

ADULT; AGED; ANTERIOR SPINE FUSION; ANTERIOR THORACIC SPINAL FUSION; ARTICLE; BODY POSITION; BONE ALLOGRAFT; BONE GRAFT; CASE REPORT; CERVICAL SPINE FRACTURE; COMPUTER ASSISTED TOMOGRAPHY; CORPECTOMY; DIURESIS; DYSPNEA; FEMALE; HOSPITAL DISCHARGE; HUMAN; INCISION; LUNG; MALE; MINIMALLY INVASIVE SURGERY; OSTEOPOROSIS; PEDICLE SCREW; PLEURA EFFUSION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PSEUDARTHROSIS; RETRACTOR; SCHEUERMANN DISEASE; SPINE SURGERY; SURGICAL RISK; SURGICAL TECHNIQUE; SYMPTOM; TACHYCARDIA; TACHYPNEA; THORACIC SPINE; THORACOTOMY; THORAX RADIOGRAPHY; TREATMENT DURATION; TUBE;

AGED; BONE MORPHOGENETIC PROTEIN 2; FEMALE; HUMANS; MALE; PLEURAL EFFUSION; SPINAL FUSION; THORACIC VERTEBRAE; TIME FACTORS; YOUNG ADULT;

EID: 79952317585     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e3181f55057     Document Type: Article

References (43)

1. Urist MR. Bone: formation by autoinduction. Science 1965;150:893-9.
2. Chen D, Zhao M, Mundy GR. Bone morphogenetic proteins. Growth Factors 2004;22:233-41. (Pubitemid 40136452)
3. Schultz DG. Letter of Approval - Bone Morphogenetic Protein P000058. Department of Health and Human Services, Center for Devices and Radiological Health; 2002.
4. Allen RT, Lee YP, Stimson E, et al. Bone morphogenetic protein-2 (BMP-2) in the treatment of pyogenic vertebral osteomyelitis. Spine 2007;32:2996-3006. (Pubitemid 350307283)
5. Aryan HE, Lu DC, Acosta FL Jr, et al. Corpectomy followed by the placement of instrumentation with titanium cages and recombinant human bone morphogenetic protein-2 for vertebral osteomyelitis. J Neurosurg Spine 2007;6:23-30. (Pubitemid 47066036)
6. Baskin DS, Ryan P, Sonntag V, et al. A prospective, randomized, controlled cervical fusion study using recombinant human bone morphogenetic protein-2 with the CORNERSTONE-SR allograft ring and the ATLANTIS anterior cervical plate. Spine 2003;28:1219-24, discussion 1225.
7. Boden SD, Zdeblick TA, Sandhu HS, et al. The use of rhBMP-2 in interbody fusion cages. Defi nitive evidence of osteoinduction in humans: a preliminary report. Spine 2000;25:376-81. (Pubitemid 30097051)
8. Haid RW, Branch CL, Alexander JT, et al. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages. Spine J 2004;4:527-38, discussion 538-9.
9. Katayama Y, Matsuyama Y, Yoshihara H, et al. Clinical and radiographic outcomes of posterolateral lumbar spine fusion in humans using recombinant human bone morphogenetic protein-2: An average fi ve-year follow-up study. Int Orthop 2009;33:1061-7.
10. Boakye M, Mummaneni PV, Garrett M, et al. Anterior cervical discectomy and fusion involving a polyetheretherketone spacer and bone morphogenetic protein. J Neurosurg Spine 2005;2:521-5.
11. Cahill KS, Chi JH, Day A, et al. Prevalence, complications, and hospital charges associated with use of bone-morphogenetic proteins in spinal fusion procedures. JAMA 2009;302:58-66.
12. Lanman TH, Hopkins TJ. Early fi ndings in a pilot study of anterior cervical interbody fusion in which recombinant human bone morphogenetic protein-2 was used with poly(l-lactide-co-d,l-lactide) bioabsorbable implants. Neurosurg Focus 2004;16:E6.
13. Leach J, Bittar RG. BMP-7 (OP-1) safety in anterior cervical fusion surgery. J Clin Neurosci 2009;16:1417-20.
14. Perri B, Cooper M, Lauryssen C, et al. Adverse swelling associated with use of rh-BMP-2 in anterior cervical discectomy and fusion: a case study. Spine J 2007;7:235-9.
15. Shields LB, Raque GH, Glassman SD, et al. Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion. Spine 2006;31:542-7.
16. Smucker JD, Rhee JM, Singh K, et al. Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine. Spine 2006;31:2813-9. (Pubitemid 44772783)
17. Vaidya R, Carp J, Sethi A, et al. Complications of anterior cervical discectomy and fusion using recombinant human bone morphogenetic protein-2. Eur Spine J 2007;16:1257-65. (Pubitemid 350104617)
18. Brower RS, Vickroy NM. A case of psoas ossifi cation from the use of BMP-2 for posterolateral fusion at L4-L5. Spine 2008;33:E653-5.
19. Joseph V, Rampersaud YR. Heterotopic bone formation with the use of rhBMP2 in posterior minimal access interbody fusion: a CT analysis. Spine 2007;32:2885-90. (Pubitemid 351339361)
20. Wong DA, Kumar A, Jatana S, et al. Neurologic impairment from ectopic bone in the lumbar canal: a potential complication of offlabel PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2). Spine J 2008;8:1011-8.
21. Shahlaie K, Kim KD. Occipitocervical fusion using recombinant human bone morphogenetic protein-2: adverse effects due to tissue swelling and seroma. Spine 2008;33:2361-6.
22. Burkus JK, Sandhu HS, Gornet MF, et al. Use of rhBMP-2 in combination with structural cortical allografts: clinical and radiographic outcomes in anterior lumbar spinal surgery. J Bone Joint Surg Am 2005;87:1205-12.
23. Klimo P Jr, Peelle MW. Use of polyetheretherketone spacer and recombinant human bone morphogenetic protein-2 in the cervical spine: a radiographic analysis. Spine J 2009;9:959-66.
24. Kuklo TR, Rosner MK, Polly DW Jr. Computerized tomography evaluation of a resorbable implant after transforaminal lumbar interbody fusion. Neurosurg Focus 2004;16:E10.
25. Laursen M, Hoy K, Hansen ES, et al. Recombinant bone morphogenetic protein-7 as an intracorporal bone growth stimulator in unstable thoracolumbar burst fractures in humans: preliminary results. Eur Spine J 1999;8:485-90. (Pubitemid 30080570)
26. Lewandrowski KU, Nanson C, Calderon R. Vertebral osteolysis after posterior interbody lumbar fusion with recombinant human bone morphogenetic protein 2: a report of fi ve cases. Spine J 2007;7:609-14. (Pubitemid 47471438)
27. McClellan JW, Mulconrey DS, Forbes RJ, et al. Vertebral bone resorption after transforaminal lumbar interbody fusion with bone morphogenetic protein (rhBMP-2). J Spinal Disord Tech 2006;19:483-6. (Pubitemid 44526745)
28. Pradhan BB, Bae HW, Dawson EG, et al. Graft resorption with the use of bone morphogenetic protein: Lessons from anterior lumbar interbody fusion using femoral ring allografts and recombinant human bone morphogenetic protein-2. Spine 2006;31:E277-84.
29. Vaidya R, Weir R, Sethi A, et al. Interbody fusion with allograft and rhBMP-2 leads to consistent fusion but early subsidence. J Bone Joint Surg Br 2007;89:342-5. (Pubitemid 46563910)
30. Vaidya R, Sethi A, Bartol S, et al. Complications in the use of rh- BMP-2 in PEEK cages for interbody spinal fusions. J Spinal Disord Tech 2008;21:557-62.
31. Mindea SA, Shih P, Song JK. Recombinant human bone morphogenetic protein-2-induced radiculitis in elective minimally invasive transforaminal lumbar interbody fusions: a series review. Spine 2009;34:1480,4; discussion 1485.
32. Rihn JA, Patel R, Makda J, et al. Complications associated with single-level transforaminal lumbar interbody fusion. Spine J 2009;9:623-9.
33. Vaidya R. Transforaminal interbody fusion and the "off label" use of recombinant human bone morphogenetic protein-2. Spine J 2009;9:667-9.
34. Huang TJ, Hsu RW, Sum CW, et al. Complications in thoracoscopic spinal surgery: a study of 90 consecutive patients. Surg Endosc 1999;13:346-50. (Pubitemid 29185496)
35. Kim DH, Jahng TA, Balabhadra RS, et al. Thoracoscopic transdiaphragmatic approach to thoracolumbar junction fractures. Spine J 2004;4:317-28. (Pubitemid 38559923)
36. Levin R, Matusz D, Hasharoni A, et al. Mini-open thoracoscopically assisted thoracotomy versus video-assisted thoracoscopic surgery for anterior release in thoracic scoliosis and kyphosis: a comparison of operative and radiographic results. Spine J 2005;5:632-8. (Pubitemid 41683743)
37. Ringel F, Stoffel M, Stuer C, et al. Endoscopy-assisted approaches for anterior column reconstruction after pedicle screw fi xation of acute traumatic thoracic and lumbar fractures. Neurosurgery 2008;62:ONS445-52; discussion ONS452-3.
38. Verheyden AP, Hoelzl A, Lill H, et al. The endoscopically assisted simultaneous posteroanterior reconstruction of the thoracolumbar spine in prone position. Spine J 2004;4:540-9. (Pubitemid 40029171)
39. O'Shaughnessy BA, Kuklo TR, Ondra SL. Surgical treatment of vertebral osteomyelitis with recombinant human bone morphogenetic protein-2. Spine 2008;33:E132-9.
40. Benglis D, Wang MY, Levi AD. A comprehensive review of the safety profi le of bone morphogenetic protein in spine surgery. Neurosurgery 2008;62:ONS423-31; discussion ONS431.
41. Kanatani M, Sugimoto T, Kaji H, et al. Stimulatory effect of bone morphogenetic protein-2 on osteoclast-like cell formation and bone-resorbing activity. J Bone Miner Res 1995;10:1681-90.
42. Koide M, Murase Y, Yamato K, et al. Bone morphogenetic protein-2 enhances osteoclast formation mediated by interleukin-1alpha through upregulation of osteoclast differentiation factor and cyclooxygenase-2. Biochem Biophys Res Commun 1999;259:97-102. (Pubitemid 29264000)
43. Smoljanovic T, Bojanic I, Pecina M. The use of bone morphogenetic protein in lumbar spine surgery. J Bone Joint Surg Am 2009;91:2045-6; author reply 2046-7.